Literature DB >> 15283471

Preparation and characterization of enrofloxacin/carbopol complex in aqueous solution.

Myung-Kwan Chun1, Hoo-Kyun Choi.   

Abstract

Since the bitter taste of enrofloxacin apparently limit the patient compliance in the oral formulations of the antibacterial agent, the masking of the taste is essential for the improvement of the therapeutic effectiveness. Therefore, this study was carried out to examine the feasibility of taste masking of enrofloxacin by the retardation of its dissolution rate using the formation of complex between the drug and Carbopol. The complexation between Carbopol and enrofloxacin was confirmed by turbidity, UV spectrophotometry, wide angle X-ray diffraction, and differential scanning calorimetry. The enrofloxacin content in the complexes was 34% (Carbo-enrofloxacin complex I) and 57% (Carbo-enrofloxacin complex II) depending on the preparation method. The dissolution rate of enrofloxacin from the complex increased as the pH was reduced. The dissolution rate of enrofloxacin from the Carbo-enrofloxacin complex I was significantly lower than that of the enrofloxacin powder. Therefore, these observations suggest that Carbo-enrofloxacin complex I can be used to mask the taste of enrofloxacin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15283471     DOI: 10.1007/BF02980168

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Efficacy of enrofloxacin in a mouse model of sepsis.

Authors:  Andrea R Slate; Sheila Bandyopadhyay; Kevin P Francis; Mark G Papich; Brian Karolewski; Eldad A Hod; Kevin A Prestia
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

2.  Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion.

Authors:  Kaixiang Zhou; Meixia Huo; Wenjin Ma; Kun Mi; Xiangyue Xu; Samah Attia Algharib; Shuyu Xie; Lingli Huang
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

3.  Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.

Authors:  Chao Li; Kaixiang Zhou; Dongmei Chen; Wei Xu; Yanfei Tao; Yuanhu Pan; Kuiyu Meng; Muhammad Abu Bakr Shabbir; Qianying Liu; Lingli Huang; Shuyu Xie
Journal:  Int J Nanomedicine       Date:  2019-03-01

4.  Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses.

Authors:  Hanah Mesallati; Anita Umerska; Lidia Tajber
Journal:  Pharmaceutics       Date:  2019-06-09       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.